Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus

References

• Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006;1(1):6. doi:10.1186/1750-1172-1-6
   PubMed Web of Science ®Google Scholar
• Catalina MD, Owen KA, Labonte AC, Grammer AC, Lipsky PE. The pathogenesis of systemic lupus erythematosus: harnessing big data to understand the molecular basis of lupus. J Autoimmun. 2020;110:102359. doi:10.1016/j.jaut.2019.102359
   PubMed Web of Science ®Google Scholar
• Caielli S, Veiga DT, Balasubramanian P, et al. A CD4(+) T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate. Nat Med. 2019;25(1):75–81. doi:10.1038/s41591-018-0254-9
   PubMed Web of Science ®Google Scholar
• Hedrich CM. Epigenetics in SLE. Curr Rheumatol Rep. 2017;19(9):58. doi:10.1007/s11926-017-0685-1
   PubMed Web of Science ®Google Scholar
• Guo G, Wang H, Shi X, et al. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker. J Transl Med. 2018;16(1):370. doi:10.1186/s12967-018-1739-5
   PubMed Web of Science ®Google Scholar
• Guo G, Wang H, Ye L, et al. Hsa_circ_0000479 as a novel diagnostic biomarker of systemic lupus erythematosus. Front Immunol. 2019;10:2281. doi:10.3389/fimmu.2019.02281
   PubMed Web of Science ®Google Scholar
• Shi L, Li S, Maurer K, Zhang Z, Petri M, Sullivan KE. Enhancer RNA and NFκΒ-dependent P300 regulation of ADAMDEC1. Mol Immunol. 2018;103:312–321. doi:10.1016/j.molimm.2018.09.019
   PubMed Web of Science ®Google Scholar
• Arnold PR, Wells AD, Li XC. Diversity and emerging roles of enhancer RNA in regulation of gene expression and cell fate. Front Cell Dev Biol. 2019;7:377. doi:10.3389/fcell.2019.00377
   PubMed Web of Science ®Google Scholar
• Li W, Notani D, Rosenfeld MG. Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat Rev Genet. 2016;17(4):207–223. doi:10.1038/nrg.2016.4
   PubMed Web of Science ®Google Scholar
• Mao R, Wu Y, Ming Y, et al. Enhancer RNAs: a missing regulatory layer in gene transcription. Sci China Life Sci. 2019;62(7):905–912. doi:10.1007/s11427-017-9370-9
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee J-H, Ruan H, et al. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. Nat Commun. 2019;10(1):4562. doi:10.1038/s41467-019-12543-5
   PubMed Web of Science ®Google Scholar
• Yamagata K, Nakayamada S, Tanaka Y. Critical roles of super-enhancers in the pathogenesis of autoimmune diseases. Inflam Regen. 2020;40:16. doi:10.1186/s41232-020-00124-9
   PubMed Web of Science ®Google Scholar
• Wu M, Shen J. From super-enhancer non-coding RNA to immune checkpoint: frameworks to functions. Front Oncol. 2019;9:1307. doi:10.3389/fonc.2019.01307
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–319. doi:10.1016/j.cell.2013.03.035
   PubMed Web of Science ®Google Scholar
• Kim YJ, Xie P, Cao L, Zhang MQ, Kim TH. Global transcriptional activity dynamics reveal functional enhancer RNAs. Genome Res. 2018;28(12):1799–1811. doi:10.1101/gr.233486.117
   PubMed Web of Science ®Google Scholar
• Sartorelli V, Lauberth SM. Enhancer RNAs are an important regulatory layer of the epigenome. Nat Struct Mol Biol. 2020;27(6):521–528. doi:10.1038/s41594-020-0446-0
   PubMed Web of Science ®Google Scholar
• Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507(7493):455–461. doi:10.1038/nature12787
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Stamatoyannopoulos JA, Costello JF, et al. The NIH roadmap epigenomics mapping consortium. Nat Biotechnol. 2010;28(10):1045–1048. doi:10.1038/nbt1010-1045
   PubMed Web of Science ®Google Scholar
• Ashoor H, Kleftogiannis D, Radovanovic A, Bajic VB. DENdb: database of integrated human enhancers [database]. Database. 2015;2015:bav085. doi:10.1093/database/bav085
   PubMedGoogle Scholar
• Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357–360. doi:10.1038/nmeth.3317
   PubMed Web of Science ®Google Scholar
• Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290–295. doi:10.1038/nbt.3122
   PubMed Web of Science ®Google Scholar
• Dorighi KM, Swigut T, Henriques T, et al. Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation. Mol Cell. 2017;66(4):e564: 568–576.e4. doi:10.1016/j.molcel.2017.04.018
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi:10.1093/bioinformatics/btp616
   PubMed Web of Science ®Google Scholar
• Azofeifa JG, Allen MA, Hendrix JR, Read T, Rubin JD, Dowell RD. Enhancer RNA profiling predicts transcription factor activity. Genome Res. 2018;28(3):334–344. doi:10.1101/gr.225755.117
   PubMed Web of Science ®Google Scholar
• Zhang H-M, Chen H, Liu W, et al. AnimalTFDB: a comprehensive animal transcription factor database. Nucleic Acids Res. 2012;40(D1):D144–D149. doi:10.1093/nar/gkr965
   PubMed Web of Science ®Google Scholar
• Chen X, Li A, Sun BF, et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019;21(8):978–990. doi:10.1038/s41556-019-0361-y
   PubMed Web of Science ®Google Scholar
• Afyouni S, Smith SM, Nichols TE. Effective degrees of freedom of the Pearson’s correlation coefficient under autocorrelation. Neuroimage. 2019;199:609–625. doi:10.1016/j.neuroimage.2019.05.011
   PubMed Web of Science ®Google Scholar
• Fornes O, Castro-Mondragon JA, Khan A, et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2020;48(D1):D87–D92. doi:10.1093/nar/gkz1001
   PubMed Web of Science ®Google Scholar
• Grant CE, Bailey TL, Noble WS. FIMO: scanning for occurrences of a given motif. Bioinformatics. 2011;27(7):1017–1018. doi:10.1093/bioinformatics/btr064
   PubMed Web of Science ®Google Scholar
• Lovén J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320–334. doi:10.1016/j.cell.2013.03.036
   PubMed Web of Science ®Google Scholar
• Chang HC, Huang HC, Juan HF, Hsu CL. Investigating the role of super-enhancer RNAs underlying embryonic stem cell differentiation. BMC Genom. 2019;20(Suppl10):896. doi:10.1186/s12864-019-6293-x
   PubMed Web of Science ®Google Scholar
• Alvarez-Dominguez JR, Knoll M, Gromatzky AA, Lodish HF. The super-enhancer-derived alncRNA-EC7/bloodlinc potentiates red blood cell development in trans. Cell Rep. 2017;19(12):2503–2514. doi:10.1016/j.celrep.2017.05.082
   PubMed Web of Science ®Google Scholar
• Pflegerl P, Vesely P, Hantusch B, et al. Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci U S A. 2009;106(48):20423–20428. doi:10.1073/pnas.0910371106
   PubMed Web of Science ®Google Scholar
• Vizcaíno C, Mansilla S, Portugal J. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 2015;152:111–124. doi:10.1016/j.pharmthera.2015.05.008
   PubMed Web of Science ®Google Scholar
• Hikami K, Kawasaki A, Ito I, et al. Association of a functional polymorphism in the 3′-untranslated region of SPI1 with systemic lupus erythematosus. Arthritis Rheum. 2011;63(3):755–763. doi:10.1002/art.30188
   PubMed Web of Science ®Google Scholar
• Nakayama K, Kim KW, Miyajima A. A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3. EMBO J. 2002;21(22):6174–6184. doi:10.1093/emboj/cdf596
   PubMed Web of Science ®Google Scholar
• Zhu L, Yang X, Chen W, et al. Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus. Clin Rheumatol. 2007;26(9):1481–1489. doi:10.1007/s10067-006-0531-8
   PubMed Web of Science ®Google Scholar
• Zhu LJ, Landolt-Marticorena C, Li T, et al. Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus. J Rheumatol. 2010;37(8):1658–1666. doi:10.3899/jrheum.091123
   PubMed Web of Science ®Google Scholar
• Sozzani S, Bosisio D, Scarsi M, Tincani A. Type I interferons in systemic autoimmunity. Autoimmunity. 2010;43(3):196–203. doi:10.3109/08916930903510872
   PubMed Web of Science ®Google Scholar
• Pollard KM, Cauvi DM, Toomey CB, Morris KV, Kono DH. Interferon-γ and systemic autoimmunity. Discov Med. 2013;16(87):123–131.
   PubMed Web of Science ®Google Scholar
• Pan CW, Wen S, Chen L, Wei Y, Niu Y, Zhao Y. Functional roles of antisense enhancer RNA for promoting prostate cancer progression. Theranostics. 2021;11(4):1780–1794. doi:10.7150/thno.51931
   PubMed Web of Science ®Google Scholar
• Carullo NVN, Phillips RA III, Simon RC, et al. Enhancer RNAs predict enhancer-gene regulatory links and are critical for enhancer function in neuronal systems. Nucleic Acids Res. 2020;48(17):9550–9570. doi:10.1093/nar/gkaa671
   PubMed Web of Science ®Google Scholar
• Cheng J, Kapranov P, Drenkow J, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005;308(5725):1149–1154. doi:10.1126/science.1108625
   PubMed Web of Science ®Google Scholar
• Carroll JS, Meyer CA, Song J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38(11):1289–1297. doi:10.1038/ng1901
   PubMed Web of Science ®Google Scholar
• Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465(7295):182–187. doi:10.1038/nature09033
   PubMed Web of Science ®Google Scholar
• Mirtschink P, Bischof C, Pham MD, et al. Inhibition of the hypoxia-inducible factor 1α-induced cardiospecific HERNA1 enhance-templated RNA protects from heart disease. Circulation. 2019;139(24):2778–2792. doi:10.1161/CIRCULATIONAHA.118.036769
   PubMed Web of Science ®Google Scholar
• Aune TM, Crooke PS III, Patrick AE, Tossberg JT, Olsen NJ, Spurlock CF. Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants. J Autoimmun. 2017;81:99–109. doi:10.1016/j.jaut.2017.03.014
   PubMed Web of Science ®Google Scholar
• Sigova AA, Abraham BJ, Ji X, et al. Transcription factor trapping by RNA in gene regulatory elements. Science. 2015;350(6263):978–981. doi:10.1126/science.aad3346
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–947. doi:10.1016/j.cell.2013.09.053
   PubMed Web of Science ®Google Scholar
• Crow MK, Olferiev M, Kirou KA. Targeting of type I interferon in systemic autoimmune diseases. Transl Res. 2015;165(2):296–305. doi:10.1016/j.trsl.2014.10.005
   PubMed Web of Science ®Google Scholar
• Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716–730. doi:10.1038/nrrheum.2016.186
   PubMed Web of Science ®Google Scholar
• Beishline K, Azizkhan-Clifford J. Sp1 and the “hallmarks of cancer”. FEBS J. 2015;282(2):224–258. doi:10.1111/febs.13148
   PubMed Web of Science ®Google Scholar
• Postal M, Appenzeller S. The role of tumor necrosis factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus. Cytokine. 2011;56(3):537–543. doi:10.1016/j.cyto.2011.08.026
   PubMed Web of Science ®Google Scholar
• Aringer M, Smolen JS. The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther. 2008;10(1):202. doi:10.1186/ar2341
   PubMed Web of Science ®Google Scholar
• Chyuan I-T, Tzeng H-T, Chen J-Y. Signaling pathways of type I and type III interferons and targeted therapies in systemic lupus erythematosus. Cells. 2019;8(9):963. doi:10.3390/cells8090963
   PubMed Web of Science ®Google Scholar